Megestrol Acetate

Form: Tablet

Strength: 20 mg, 40 mg, 160 mg, 625 mg

Reference Brands: Megace(US & EU), Megestat®, Megaplex®, Megacephin®(EU)

Category: Oncology Cancer Care

Megestrol Acetate Tablets are oral hormone-based therapies widely used in oncology for treating advanced breast and endometrial cancers, as well as cancer-related cachexia. Available in 20 mg, 40 mg, 160 mg, and 625 mg strengths, Megestrol Acetate is approved in both the U.S. and EU markets. It works by modifying hormone levels to inhibit cancer cell growth and stimulate appetite in patients suffering from weight loss. A key product in oncology B2B distribution, Megestrol Acetate is essential for improving quality of life and managing hormone-responsive cancers and cancer-induced anorexia.